Skip to main content
Top
Published in: European Journal of Epidemiology 7/2011

01-07-2011 | COMMENTARY

In search of the causes of Parkinson’s disease, seasons 1 to 4

Author: Alexis Elbaz

Published in: European Journal of Epidemiology | Issue 7/2011

Login to get access

Excerpt

A comprehensive review on the etiology and epidemiology of Parkinson’s disease (PD), authored by Wirdefeldt and colleagues, is published as a separate supplement by the European Journal of Epidemiology [1]. The authors have undertaken an enormous task, reviewing and synthesizing evidence from over 600 references covering descriptive epidemiology, pre-symptomatic symptoms, genetic epidemiology, and several risk or protective factors of PD. This review provides an up-to-date reference guide and I am certain that it will be of interest to a wide range of scientists and largely cited by them. In another paper from this issue of the Journal, Wang and colleagues investigate the relation between Parkinson’s disease and ambient exposure to pesticides in the Central Valley of California using an innovative method of exposure assessment [2]. …
Literature
1.
go back to reference Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J. Epidemiology and etiology of Parkinson’s disease: a review of the evidence. Eur J Epidemiol. 2011. doi:10.1007/s10654-011-9581-6. Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J. Epidemiology and etiology of Parkinson’s disease: a review of the evidence. Eur J Epidemiol. 2011. doi:10.​1007/​s10654-011-9581-6.
2.
3.
go back to reference Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 1983;219:979–80.CrossRefPubMed Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 1983;219:979–80.CrossRefPubMed
4.
go back to reference Priyadarshi A, Khuder SA, Schaub EA, Shrivastava S. A meta-analysis of Parkinson’s disease and exposure to pesticides. Neurotoxicology. 2000;21:435–40.PubMed Priyadarshi A, Khuder SA, Schaub EA, Shrivastava S. A meta-analysis of Parkinson’s disease and exposure to pesticides. Neurotoxicology. 2000;21:435–40.PubMed
5.
go back to reference Priyadarshi A, Khuder SA, Schaub EA, Priyadarshi SS. Environmental risk factors and Parkinson’s disease: a metaanalysis. Environ Res. 2001;86:122–7.CrossRefPubMed Priyadarshi A, Khuder SA, Schaub EA, Priyadarshi SS. Environmental risk factors and Parkinson’s disease: a metaanalysis. Environ Res. 2001;86:122–7.CrossRefPubMed
6.
go back to reference Brown TP, Rumsby PC, Capleton AC, Rushton L, Levy LS. Pesticides and Parkinson’s disease–is there a link? Environ Health Perspect. 2006;114:156–64.CrossRefPubMed Brown TP, Rumsby PC, Capleton AC, Rushton L, Levy LS. Pesticides and Parkinson’s disease–is there a link? Environ Health Perspect. 2006;114:156–64.CrossRefPubMed
7.
go back to reference Hernan MA, Takkouche B, CaamanoIsorna F, GestalOtero JJ. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson’s disease. Ann Neurol. 2002;52:276–84.CrossRefPubMed Hernan MA, Takkouche B, CaamanoIsorna F, GestalOtero JJ. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson’s disease. Ann Neurol. 2002;52:276–84.CrossRefPubMed
8.
go back to reference Ritz B, Ascherio A, Checkoway H, Marder KS, Nelson LM, Rocca WA, et al. Pooled analysis of tobacco use and risk of Parkinson disease. Arch Neurol. 2007;64:990–7.CrossRefPubMed Ritz B, Ascherio A, Checkoway H, Marder KS, Nelson LM, Rocca WA, et al. Pooled analysis of tobacco use and risk of Parkinson disease. Arch Neurol. 2007;64:990–7.CrossRefPubMed
9.
go back to reference Tanner CM, Goldman SM, Aston DA, Ottman R, Ellenberg J, Mayeux R, et al. Smoking and Parkinson’s disease in twins. Neurology. 2002;58:581–8.PubMed Tanner CM, Goldman SM, Aston DA, Ottman R, Ellenberg J, Mayeux R, et al. Smoking and Parkinson’s disease in twins. Neurology. 2002;58:581–8.PubMed
10.
go back to reference Wirdefeldt K, Gatz M, Pawitan Y, Pedersen NL. Risk and protective factors for Parkinson’s disease: a study in Swedish twins. Ann Neurol. 2005;57:27–33.CrossRefPubMed Wirdefeldt K, Gatz M, Pawitan Y, Pedersen NL. Risk and protective factors for Parkinson’s disease: a study in Swedish twins. Ann Neurol. 2005;57:27–33.CrossRefPubMed
11.
go back to reference Elbaz A, Bower JH, Peterson BJ, Maraganore D, McDonnell SK, Ahlskog JE, et al. Survival study of Parkinson disease in Olmsted County, Minnesota. Arch Neurol. 2003;60:91–6.CrossRefPubMed Elbaz A, Bower JH, Peterson BJ, Maraganore D, McDonnell SK, Ahlskog JE, et al. Survival study of Parkinson disease in Olmsted County, Minnesota. Arch Neurol. 2003;60:91–6.CrossRefPubMed
12.
go back to reference Chen H, Zhang SM, Schwarzschild MA, Hernan MA, Ascherio A. Survival of Parkinson’s disease patients in a large prospective cohort of male health professionals. Mov Disord. 2006;21:1002–7.CrossRefPubMed Chen H, Zhang SM, Schwarzschild MA, Hernan MA, Ascherio A. Survival of Parkinson’s disease patients in a large prospective cohort of male health professionals. Mov Disord. 2006;21:1002–7.CrossRefPubMed
13.
go back to reference Chen H, Huang X, Guo X, Mailman RB, Park Y, Kamel F, et al. Smoking duration, intensity, and risk of Parkinson disease. Neurology. 2010;74:878–84.CrossRefPubMed Chen H, Huang X, Guo X, Mailman RB, Park Y, Kamel F, et al. Smoking duration, intensity, and risk of Parkinson disease. Neurology. 2010;74:878–84.CrossRefPubMed
14.
go back to reference Ritz B, Rhodes SL. After half a century of research on smoking, PD, where do we go now? Neurology. 2010;74:870–1.CrossRefPubMed Ritz B, Rhodes SL. After half a century of research on smoking, PD, where do we go now? Neurology. 2010;74:870–1.CrossRefPubMed
15.
go back to reference Mellick GD, Gartner CE, Silburn PA, Battistuta D. Passive smoking and Parkinson’s disease. Neurology. 2006;67:179–80.CrossRefPubMed Mellick GD, Gartner CE, Silburn PA, Battistuta D. Passive smoking and Parkinson’s disease. Neurology. 2006;67:179–80.CrossRefPubMed
16.
go back to reference O’Reilly EJ, Chen H, Gardener H, Gao X, Schwarzschild MA, Ascherio A. Smoking and Parkinson’s disease: using parental smoking as a proxy to explore causality. Am J Epidemiol. 2009;169:678–82. O’Reilly EJ, Chen H, Gardener H, Gao X, Schwarzschild MA, Ascherio A. Smoking and Parkinson’s disease: using parental smoking as a proxy to explore causality. Am J Epidemiol. 2009;169:678–82.
17.
go back to reference Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor R, et al. Inhibition of monoamine oxidase B in the brains of smokers. Nature. 1996;379:733–6.CrossRefPubMed Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor R, et al. Inhibition of monoamine oxidase B in the brains of smokers. Nature. 1996;379:733–6.CrossRefPubMed
18.
go back to reference Hong DP, Fink AL, Uversky VN. Smoking and Parkinson’s disease: does nicotine affect alpha-synuclein fibrillation? Biochim Biophys Acta. 2009;1794:282–90.PubMed Hong DP, Fink AL, Uversky VN. Smoking and Parkinson’s disease: does nicotine affect alpha-synuclein fibrillation? Biochim Biophys Acta. 2009;1794:282–90.PubMed
19.
20.
go back to reference Tan LC, Koh WP, Yuan JM, Wang R, Au WL, Tan JH, et al. Differential effects of black versus green tea on risk of Parkinson’s disease in the Singapore Chinese Health Study. Am J Epidemiol. 2008;167:553–60.CrossRefPubMed Tan LC, Koh WP, Yuan JM, Wang R, Au WL, Tan JH, et al. Differential effects of black versus green tea on risk of Parkinson’s disease in the Singapore Chinese Health Study. Am J Epidemiol. 2008;167:553–60.CrossRefPubMed
21.
go back to reference Stacy M, Silver D, Mendis T, Sutton J, Mori A, Chaikin P, et al. A 12-week, placebo-controlled study (6002-US-006) of istradefylline in Parkinson disease. Neurology. 2008;70:2233–40.CrossRefPubMed Stacy M, Silver D, Mendis T, Sutton J, Mori A, Chaikin P, et al. A 12-week, placebo-controlled study (6002-US-006) of istradefylline in Parkinson disease. Neurology. 2008;70:2233–40.CrossRefPubMed
23.
go back to reference Kamel F, Tanner C, Umbach D, Hoppin J, Alavanja M, Blair A, et al. Pesticide exposure and self-reported Parkinson’s disease in the agricultural health study. Am J Epidemiol. 2007;165:364–74.CrossRefPubMed Kamel F, Tanner C, Umbach D, Hoppin J, Alavanja M, Blair A, et al. Pesticide exposure and self-reported Parkinson’s disease in the agricultural health study. Am J Epidemiol. 2007;165:364–74.CrossRefPubMed
24.
go back to reference Elbaz A, Clavel J, Rathouz PJ, Moisan F, Galanaud JP, Delemotte B, et al. Professional exposure to pesticides and Parkinson’s disease. Ann Neurol. 2009;66:494–504.CrossRefPubMed Elbaz A, Clavel J, Rathouz PJ, Moisan F, Galanaud JP, Delemotte B, et al. Professional exposure to pesticides and Parkinson’s disease. Ann Neurol. 2009;66:494–504.CrossRefPubMed
25.
go back to reference Dick FD, De PG, Ahmadi A, Scott NW, Prescott GJ, Bennett J, et al. Environmental risk factors for Parkinson’s disease and Parkinsonism: the Geoparkinson study. Occup Environ Med. 2007;64:666–72.CrossRefPubMed Dick FD, De PG, Ahmadi A, Scott NW, Prescott GJ, Bennett J, et al. Environmental risk factors for Parkinson’s disease and Parkinsonism: the Geoparkinson study. Occup Environ Med. 2007;64:666–72.CrossRefPubMed
26.
go back to reference Hatcher JM, Pennell KD, Miller GW. Parkinson’s disease and pesticides: a toxicological perspective. Trends Pharmacol Sci. 2008;29:322–9.CrossRefPubMed Hatcher JM, Pennell KD, Miller GW. Parkinson’s disease and pesticides: a toxicological perspective. Trends Pharmacol Sci. 2008;29:322–9.CrossRefPubMed
27.
go back to reference Cory-Slechta DA, Thiruchelvam M, Barlow BK, Richfield EK. Developmental pesticide models of the Parkinson disease phenotype. Environ Health Perspect. 2005;113:1263–70.CrossRefPubMed Cory-Slechta DA, Thiruchelvam M, Barlow BK, Richfield EK. Developmental pesticide models of the Parkinson disease phenotype. Environ Health Perspect. 2005;113:1263–70.CrossRefPubMed
28.
go back to reference Gatto NM, Rhodes SL, Manthripragada AD, Bronstein J, Cockburn M, Farrer M, et al. Alpha-Synuclein gene may interact with environmental factors in increasing risk of Parkinson’s disease. Neuroepidemiology. 2010;35:191–5.CrossRefPubMed Gatto NM, Rhodes SL, Manthripragada AD, Bronstein J, Cockburn M, Farrer M, et al. Alpha-Synuclein gene may interact with environmental factors in increasing risk of Parkinson’s disease. Neuroepidemiology. 2010;35:191–5.CrossRefPubMed
29.
go back to reference Manthripragada AD, Costello S, Cockburn MG, Bronstein JM, Ritz B. Paraoxonase 1, agricultural organophosphate exposure, and Parkinson disease. Epidemiology. 2010;21:87–94.CrossRefPubMed Manthripragada AD, Costello S, Cockburn MG, Bronstein JM, Ritz B. Paraoxonase 1, agricultural organophosphate exposure, and Parkinson disease. Epidemiology. 2010;21:87–94.CrossRefPubMed
30.
go back to reference Dick FD, De PG, Ahmadi A, Osborne A, Scott NW, Prescott GJ, et al. Gene-environment interactions in Parkinsonism and Parkinson’s disease: the Geoparkinson study. Occup Environ Med. 2007;64:673–80.CrossRefPubMed Dick FD, De PG, Ahmadi A, Osborne A, Scott NW, Prescott GJ, et al. Gene-environment interactions in Parkinsonism and Parkinson’s disease: the Geoparkinson study. Occup Environ Med. 2007;64:673–80.CrossRefPubMed
31.
go back to reference Dutheil F, Beaune P, Tzourio C, Loriot M-A, Elbaz A. Interaction between ABCB1 and professional exposure to organochlorine insecticides in Parkinson’s disease. Arch Neurol. 2010;67:739–45.CrossRefPubMed Dutheil F, Beaune P, Tzourio C, Loriot M-A, Elbaz A. Interaction between ABCB1 and professional exposure to organochlorine insecticides in Parkinson’s disease. Arch Neurol. 2010;67:739–45.CrossRefPubMed
32.
go back to reference Kiyohara C, Miyake Y, Koyanagi M, Fujimoto T, Shirasawa S, Tanaka K, et al. GST polymorphisms, interaction with smoking and pesticide use, and risk for Parkinson’s disease in a Japanese population. Parkinsonism Relat Disord. 2010;16:447–52.CrossRefPubMed Kiyohara C, Miyake Y, Koyanagi M, Fujimoto T, Shirasawa S, Tanaka K, et al. GST polymorphisms, interaction with smoking and pesticide use, and risk for Parkinson’s disease in a Japanese population. Parkinsonism Relat Disord. 2010;16:447–52.CrossRefPubMed
33.
go back to reference Elbaz A, Ross OA, Ioannidis JP, Soto-Ortolaza AI, Moisan F, Aasly J et al. Independent and joint effects of the MAPT and SNCA genes in Parkinson disease. Ann Neurol. 2011;69:778–92. Elbaz A, Ross OA, Ioannidis JP, Soto-Ortolaza AI, Moisan F, Aasly J et al. Independent and joint effects of the MAPT and SNCA genes in Parkinson disease. Ann Neurol. 2011;69:778–92.
34.
go back to reference International Parkinson Disease Genomics Consortium. Imputation of sequence variants for identification of genetic risks for Parkinson’s disease: a meta-analysis of genome-wide association studies. Lancet. 2011;377:641–9.CrossRef International Parkinson Disease Genomics Consortium. Imputation of sequence variants for identification of genetic risks for Parkinson’s disease: a meta-analysis of genome-wide association studies. Lancet. 2011;377:641–9.CrossRef
35.
go back to reference Tanner CM, Kamel F, Ross GW, Hoppin JA, Goldman SM, Korell M et al. Rotenone, Paraquat and Parkinson’s disease. Environ Health Perspect. 2011; doi:10.1289/ehp.1002839. Tanner CM, Kamel F, Ross GW, Hoppin JA, Goldman SM, Korell M et al. Rotenone, Paraquat and Parkinson’s disease. Environ Health Perspect. 2011; doi:10.​1289/​ehp.​1002839.
Metadata
Title
In search of the causes of Parkinson’s disease, seasons 1 to 4
Author
Alexis Elbaz
Publication date
01-07-2011
Publisher
Springer Netherlands
Published in
European Journal of Epidemiology / Issue 7/2011
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-011-9587-0

Other articles of this Issue 7/2011

European Journal of Epidemiology 7/2011 Go to the issue